Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

BU researchers identify biomarker and possible new therapy for melanoma

Researchers have identified a biomarker and a possible new therapy for melanoma.

26 Mar 2019

New research illuminates positive effects of exercise on the brain

Anyone who trains for a marathon knows that individual running workouts add up over time to yield a big improvement in physical fitness.

25 Mar 2019

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable Eisai to use Cerveau's [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography scans to assess the status and progression of neurofibrillary tangles in the brain.

25 Mar 2019

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

22 Mar 2019

Q BioMed and Mannin Research collaborate with McMaster University to develop GDF15 biomarker glaucoma diagnostic kit

Q BioMed Inc., a commercial stage biotechnology acceleration development company, announced today that its technology partner Mannin Research Inc. has entered into a research collaboration with the Biointerfaces Institute at McMaster University in Ontario, Canada to develop a GDF15 biomarker diagnostic kit for monitoring glaucoma severity and progression.

From Q BioMed Inc. 21 Mar 2019

Roundworm study suggests alternatives for treatment of schizophrenia

A group of Brazilian scientists have long conducted experiments with roundworms to investigate the role of schizophrenia-linked genes in patients' response to antipsychotic drugs. The results obtained thus far point to new ways of understanding resistance to certain classes of medication.

20 Mar 2019

Sphingotec reports new applications of bio-ADM at 39th ISICEM

Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.

20 Mar 2019

Researchers identify origin of chronic pain in humans

A new study by researchers at The University of Texas at Dallas, UT MD Anderson Cancer Center, UT Health Science Center at Houston and Baylor College of Medicine has produced evidence of the source of chronic pain in humans, revealing several new targets for pain treatment.

19 Mar 2019

Latest advances and perspectives of all AI types used in pharmaceutical R&D

The advances in Artificial intelligence have successfully propagated into the many areas such as computer vision, speech recognition, and natural language processing.

19 Mar 2019

Proteins in the eye may be potential source for cost-effective test to predict Alzheimer's disease

Low levels of amyloid-β and tau proteins, biomarkers of Alzheimer's disease, in eye fluid were significantly associated with low cognitive scores, according to a new study published in the Journal of Alzheimer's Disease.

19 Mar 2019

Researchers hope blood test that accurately diagnoses fibromyalgia could be available within five years

Ohio State University researchers have evidence that blood samples can reliably detect fibromyalgia, a disease that is often misdiagnosed due to its general symptoms that characterize a number of other conditions.

18 Mar 2019

Researchers discover new biomarker for postoperative liver dysfunction

Postoperative liver dysfunction (failure) is the most serious complication that can occur following liver resection (full or partial hepatectomy) to remove liver tumors.

18 Mar 2019

Researchers use MRI and AI techniques at birth to predict cognitive development at age 2

Researchers at the University of North Carolina School of Medicine used MRI brain scans and machine learning techniques at birth to predict cognitive development at age 2 years with 95 percent accuracy.

15 Mar 2019

USP15 enzyme could potentially lead to new treatments for breast, pancreatic cancer

Researchers at the George Washington University Cancer Center found that the enzyme USP15 could potentially lead to new treatments for breast and pancreatic cancer. Their findings were published in Nature Communications.

15 Mar 2019

New clinical development user's guide for kidney safety biomarkers

The Critical Path Institute's (C-Path) Predictive Safety Testing Consortium (PSTC) today announced availability of the User's Guide: Kidney Safety Composite Measure Biomarker for Use in Clinical Development.

15 Mar 2019

Insilico Medicine announces partnership with Master Investor

Insilico Medicine a biotechnology company specializing in the application of artificial intelligence for drug discovery, biomarker development, and aging research has announced its second year of partnership with Master Investor at the annual Master Investor Show.

From Insilico Medicine 14 Mar 2019

Oral bacteria in pancreas associated with tumor severity

The presence of oral bacteria in so-called cystic pancreatic tumours is associated with the severity of the tumour, a study by researchers at Karolinska Institutet in Sweden published in the journal Gut reports. It is hoped that the results can help to improve diagnosis and treatment of pancreatic cancer.

14 Mar 2019

Biomarker News and Research

Further Reading

BU researchers identify biomarker and possible new therapy for melanoma

New research illuminates positive effects of exercise on the brain

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

City of Hope exhibits current studies and data on cancer therapies at AACR

Q BioMed and Mannin Research collaborate with McMaster University to develop GDF15 biomarker glaucoma diagnostic kit

Roundworm study suggests alternatives for treatment of schizophrenia

Sphingotec reports new applications of bio-ADM at 39th ISICEM

Researchers identify origin of chronic pain in humans

Latest advances and perspectives of all AI types used in pharmaceutical R&D

Proteins in the eye may be potential source for cost-effective test to predict Alzheimer's disease

Researchers hope blood test that accurately diagnoses fibromyalgia could be available within five years

Researchers discover new biomarker for postoperative liver dysfunction

Researchers use MRI and AI techniques at birth to predict cognitive development at age 2

USP15 enzyme could potentially lead to new treatments for breast, pancreatic cancer

New clinical development user's guide for kidney safety biomarkers

Insilico Medicine announces partnership with Master Investor

Oral bacteria in pancreas associated with tumor severity

Study shows ability of non-invasive imaging technique to identify small airway damage in COPD

New, quantitative method for assessment of molecular biomarker for osteoarthritis

“Fail Fast, But More Confidently”: Developing Organoids for Drug Development and Discovery

Industry Focus eBook - Protein Analysis (3rd edition) eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo